Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
IM

Indrawan James McAlpine — 14 Patents

Pfizer: 13 patents #344 of 5,153Top 7%
ISIteos Therapeutics Sa: 2 patents #5 of 19Top 30%
APAgouron Pharmaceuticals: 1 patents #185 of 327Top 60%
San Diego, CA: #3,169 of 23,606 inventorsTop 15%
California: #43,920 of 386,348 inventorsTop 15%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Indrawan James McAlpine has been granted 14 US patents while listed as an inventor at Pfizer. The first was granted in 2006 and the most recent in May 2025. Indrawan James McAlpine ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Indrawan James McAlpine in San Diego, CA, US.

Patents per Year

Patents granted per year, 2006 to 2025Bar chart with a peak of 3 patents in 2019.peak 32006: 1 patents20062010: 1 patents20102011: 1 patents20112015: 1 patents20152016: 1 patents20162018: 1 patents20182019: 3 patents20192020: 3 patents20202021: 1 patents20212025: 1 patents2025

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12297190 Modulators of STING (stimulator of interferon genes) Ryan Patman, Martin James Wythes, Eugene Yuanjin Rui, Andrew Fensome, Mehran Jalaie +6 more 2025-05-13
10968242 Cyclopentane-based modulators of STING (stimulator of interferon genes) Martin James Wythes, Ryan Patman, Eugene Yuanjin Rui, Andreas Maderna, Mehran Jalaie +1 more 2021-04-06 $415,547,000
10709709 Substituted carbonucleoside derivatives useful as anticancer agents John Howard Tatlock, Michelle Tran-Dube, Eugene Yuanjin Rui, Martin James Wythes, Robert Arnold Kumpf +2 more 2020-07-14 $603,822,000
10544095 3-indol substituted derivatives, pharmaceutical compositions and methods for use Sacha Ninkovic, Michael Raymond Collins, Stefano Crosignani, Andreas Maderna, Stephanie Anne Scales +1 more 2020-01-28 $176,069,000
10538542 Cyclopentane-based modulators of STING (stimulator of interferon genes) Martin James Wythes, Ryan Patman, Eugene Yuanjin Rui, Andrew Fensome, Andreas Maderna +2 more 2020-01-21 $463,851,000
10428104 Substituted nucleoside derivatives useful as anticancer agents John Howard Tatlock, Michelle Tran-Dube, Eugene Yuanjin Rui, Martin James Wythes, Robert Arnold Kumpf +1 more 2019-10-01 $298,967,000
10246433 Aryl and heteroaryl fused lactams Martin Paul Edwards, Robert Arnold Kumpf, Pei-Pei Kung, Sacha Ninkovic, Eugene Yuanjin Rui +4 more 2019-04-02 $888,363,000
10220037 Substituted carbonucleoside derivatives useful as anticancer agents John Howard Tatlock, Michelle Tran-Dube, Eugene Yuanjin Rui, Martin James Wythes, Robert Arnold Kumpf +2 more 2019-03-05 $426,614,000
9873690 3-indol substituted derivatives, pharmaceutical compositions and methods for use Sacha Ninkovic, Stefano Crosignani, Michael Raymond Collins, Stephanie Anne Scales, Andreas Maderna +1 more 2018-01-23 $117,720,000
9328096 Tropomyosin-related kinase inhibitors Sharanjeet Kaur Bagal, Jingrong Jean Cui, Samantha Elizabeth Greasley, Elizabeth Ann Lunney, Asako Nagata +5 more 2016-05-03 $300,884,000
9040515 Aryl and heteroaryl fused lactams Martin Paul Edwards, Robert Arnold Kumpf, Pei-Pei Kung, Sacha Ninkovic, Eugene Yuanjin Rui +4 more 2015-05-26 $303,449,000
7884117 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors Junhun Zhang, Anle Yang, Susan Elizabeth Kephart, Liming Dong, Chuangxing Guo +4 more 2011-02-08 $611,669,000
7772246 Pyrazole compounds as RAF inhibitors Jingrong Jean Cui, Judith Gail Deal, Danlin Gu, Chuangxing Guo, Mary Catherine Johnson +5 more 2010-08-10 $126,194,000
7008953 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation Susan Elizabeth Kephart, Siegfried H. Reich 2006-03-07